Cepheid
Sunnyvale
About Cepheid
Cepheid is a molecular diagnostics company that is dedicated to improving healthcare by developing, manufacturing, and marketing accurate yet easy-to-use molecular systems and tests. By automating highly complex and time-consuming manual procedures, the company's solutions deliver a better way for institutions of any size to perform sophisticated genetic testing for organisms and genetic-based diseases. Through its strong molecular biology capabilities, the company is focusing on those applications where accurate, rapid, and actionable test results are needed most, such as managing infectious diseases and cancer.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Delisted
- Employees: 5,001 – 10,000
- Estimated revenue: $100K – $500K
- Total funding: $117.8M
- Funding stage: M&A
- Last round: Grant (Oct 2021)
- Ticker: nasdaq:CPHD
- Website: cepheid.com
- Phone: 4085416439
Industries & Categories
Biotechnology, Genetics, Health Care, Health Diagnostics, Medical
Social Profiles
Canonical: https://fsome.com/organization/cepheid-51274 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.